## Abstract ## Introduction. Motilityβrelated protein (MRP)β1/CD9 is implicated in cell adhesion and motility and was shown to be clearly involved in tumor prognosis and angiogenesis. Elevated MRPβ1/CD9 expression on tumor cells has been linked to a favorable prognosis in breast cancer, colon canc
Expression of CD9/motility-related protein 1 (MRP-1) in renal parenchymal neoplasms: Consistent expression in papillary and chromophobe renal cell carcinomas
β Scribed by Naoto Kuroda; Keiji Inoue; Limei Guo; Eriko Miyazaki; Yoshihiro Hayashi; Keishi Naruse; Makoto Toi; Makoto Hiroi; Taro Shuin; Hideaki Enzan
- Book ID
- 117818496
- Publisher
- Elsevier Science
- Year
- 2001
- Tongue
- English
- Weight
- 379 KB
- Volume
- 32
- Category
- Article
- ISSN
- 1532-8392
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND CD9 has been implicated in cell adhesion, motility, and proliferation, and numerous studies have demonstrated its prognostic value in different solid tumors. The objective of this study was to determine the relation of CD9 expression to tumor grade and tumor stage of urot
Motility-related protein-1 (MRP-1)/CD9 is a trans-membrane glycoprotein closely associated with suppression of cell motility and reduced metastatic potential of some tumor cells. We currently report that, according to the RT-PCR method for MRP-1/CD9 gene expression, patients with low expression of M